GenSight Biologics S.A.

GSGTF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income-$7-$8-$6-$14
Dep. & Amort.$0-$0$1$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC$5$1$0$6
Other Non-Cash-$2$2-$3-$3
Operating Cash Flow-$3-$6-$7-$8
Investing Activities
PP&E Inv.$0$0-$0-$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$0$0$0$0
Investing Cash Flow-$0$0$0$0
Financing Activities
Debt Repay.-$0-$2-$0$0
Stock Issued$1$17$0$0
Stock Repurch.$0-$0-$0-$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$13$13$10
Financing Cash Flow$1$1$12$9
Forex Effect$0-$0$0$0
Net Chg. in Cash-$2-$4$7$1
Supplemental Information
Beg. Cash$3$7$2$1
End Cash$0$2$7$1
Free Cash Flow-$3-$6-$7-$8